Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-5,035
Closed -$351K – 725
2015
Q4
$351K Hold
5,035
– – 0.01% 471
2015
Q3
$364K Hold
5,035
– – 0.01% 444
2015
Q2
$400K Sell
5,035
-400
-7% -$32.9K 0.01% 470
2015
Q1
$442K Hold
5,435
– – 0.01% 435
2014
Q4
$412K Buy
5,435
+400
+8% +$30.1K 0.01% 452
2014
Q3
$368K Sell
5,035
-800
-14% -$58.6K 0.01% 476
2014
Q2
$422K Buy
5,835
+450
+8% +$31.3K 0.01% 458
2014
Q1
$371K Buy
+5,385
New +$358K 0.01% 439

Other funds holding DVA

Geneva Advisors's DVA Position: Q1 2016 in Review

Geneva Advisors sold out of DaVita (DVA) in Q1 2016, closing a stake of 5,035 shares — an estimated $351K sold.

Geneva Advisors first reported a position in DVA in Q1 2014 and held it in 8 quarters. The position peaked at $442K in Q1 2015. 475 funds tracked by Wall St. Rank hold DVA as of Q1 2016.

  • Geneva Advisors reported no remaining DaVita position as of Q1 2016 after selling out during the quarter.
  • Geneva Advisors sold 5,035 DaVita shares in Q1 2016, an estimated $351K.
  • Geneva Advisors first reported a position in DaVita in Q1 2014 and held it in 8 quarters.
  • Geneva Advisors's DaVita position peaked at $442K in Q1 2015.
  • 475 funds tracked by Wall St. Rank held DaVita as of Q1 2016.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.